Treatment advances for fibroids, menopause

May 03, 2008

Women with fibroids and endometriosis facing the possibility of hysterectomy may now choose less invasive treatment options to preserve fertility, according to Yale professor Aydin Arici, M.D., who will direct a scientific session exploring these alternatives at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting May 3-7 in New Orleans, Louisiana.

Arici will chair the two-day postgraduate ACOG course “Current Topics in Reproductive Endocrinology for the Clinician.” He joins colleagues in the Yale Department of Obstetrics, Gynecology & Reproductive Sciences as they lead other ACOG courses on menopause, managing post-term pregnancy, and managing patients with bleeding disorders during pregnancy.

In his course, Arici will present treatment options for endometriosis and share novel conservative approaches for treating fibroids, the most common benign tumor seen in reproductive-age women and the leading cause of hysterectomy in the United States.

“Our goal is to educate general obstetricians on ways to tailor new treatment techniques to the needs of individual patients,” said Arici. “For women in their 30s and 40s, preserving reproductive potential while treating fibroids is often desired. In the past, ovarian function was suppressed by inducing sudden menopause to shrink fibroids. Novel medications that were unavailable a few years back are now able to do so without unpleasant side effects.”

Arici said that conservative treatment options include a medical approach using selective estrogen receptor modulators and selective progesterone receptor modulators, uterine artery embolization, MRI-focused high-energy ultrasound, and conservative surgery using abdominal myomectomy, hysterectomy to remove the fibroids, but preserve the reproductive capacity of the uterus.

Yale Ob/Gyn reproductive endocrinologist Lubna Pal’s ACOG course will explore the biological, psychosocial and behavioral consequences of women’s transition into menopause and the postmenopausal years. One of her goals is to help doctors understand the predictors of menopause, and the treatment needs of women who have undergone hysterectomies or oophorectomies.

Errol Norwitz, M.D., will lead an interactive session on managing post-term or overdue pregnancies. He and his colleague will address issues such as the risks and benefits of routine induction of labor at 41 weeks gestation.

Source: Yale University

Explore further: Researcher develops, proves effectiveness of new drug for spinal muscular atrophy

add to favorites email to friend print save as pdf

Related Stories

Will the real unemployment rate please stand up?

43 minutes ago

America's unemployment rate—most recently reported as 6.1 percent—has long been used to gauge the country's economic well-being. But a new working paper released by Princeton University's Woodrow Wilson School of Public ...

Mosquito fact and fiction

2 hours ago

One of Jason Pitts' favorite stories is about mosquitoes and their strange attraction to Limburger cheese.

'Destiny' video game has $500-million debut

2 hours ago

Bungie studio's new science fiction action video game "Destiny" landed in the record books on Wednesday, boasting the biggest ever launch of a new franchise.

Recommended for you

Cellular protein may be key to longevity

17 hours ago

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions ...

Gut bacteria tire out T cells

20 hours ago

Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Me ...

T-bet tackles hepatitis

20 hours ago

A single protein may tip the balance between ridding the body of a dangerous virus and enduring life-long chronic infection, according to a report appearing in The Journal of Experimental Medicine.

User comments : 0